Publications by Dr R Neely - ePrints

Browsing publications by Dr R Neely.

Newcastle Authors	Title	Year
Dr Simon Bridge Dr David Sheridan Dr R Neely Emeritus Professor Margaret Bassendine	Autoantibodies to apolipoprotein A-I in hepatitis C virus infection: a role in disease progression?	2025
Dr R Neely	Lipoprotein(a) testing in lipid clinics across the UK: Results of a national survey	2024
Dr R Neely	Lp(A): When and how to measure it	2021
Dr R Neely	Corrigendum to “HEART UK consensus statement on Lipoprotein(a): A call to action” [Atherosclerosis 291 (2019) 62–70]	2020
Dr Danny Chan Dr Carmen Martin-Ruiz Dr Gabriele Saretzki Dr R Neely Professor Vijay Kunadian et al.	The association of telomere length and telomerase activity with adverse outcomes in older patients with non-ST-elevation acute coronary syndrome	2020
Dr R Neely	The clinical and laboratory investigation of dysbetalipoproteinemia	2020
Dr R Neely	Evaluation of the non-HDL cholesterol to apolipoprotein B ratio as a screening test for dysbetalipoproteinemia	2019
Dr R Neely	HEART UK consensus statement on Lipoprotein(a): A call to action	2019
Dr David Woods Dr R Neely Dr Katherine Talks Dr Alison Heggie Dr Richard Quinton et al.	Hematopoiesis Shows Closer Correlation with Calculated Free Testosterone in Men than Total Testosterone	2017
Emeritus Professor Margaret Bassendine Dr Soren Nielsen Dr Simon Bridge Dr Daniel Felmlee Dr David Sheridan et al.	Hepatitis C virus and atherosclerosis: A legacy after virologic cure?	2017
Professor Vijay Kunadian Dr R Neely Dr Hannah Sinclair Dr Jonathan Batty Dr Murugu Veerasamy et al.	A Study to Improve Cardiovascular Outcomes in High-Risk Older PatieNts (ICON-1) with Acute Coronary Syndrome: Study Design and Protocol of a Prospective Observational Study	2016
Dr Jonathan Batty Dr R Neely Professor Vijay Kunadian	PCSK₉ inhibitors in the prevention of cardiovascular disease	2016
Anna Long Dr Sarah Johnson Dr R Neely Dr David Richardson Dr James Graham et al.	Phaeochromocytoma and ACTH-dependent cushing's syndrome: tumour crf secretion can mimic pituitary cushing's disease	2016
Dr Iftikhar Fazal Dr R Neely Dr Guy MacGowan Dr Jane Skinner	Impact of using different guideline recommended serum natriuretic peptide thresholds on the diagnosis and referral rates of a diagnostic heart failure clinic	2015
Dr Simon Bridge Dr David Sheridan Dr Daniel Felmlee Fiona Fenwick Dr Clare Lanyon et al.	PCSK9, apolipoprotein E and lipoviral particles in chronic hepatitis C genotype 3: Evidence for genotype-specific regulation of lipoprotein metabolism	2015
Dr David Sheridan Dr Simon Bridge Dr Daniel Felmlee Dr R Neely Emeritus Professor Margaret Bassendine et al.	Depressive symptoms in chronic hepatitis C are associated with plasma apolipoprotein E deficiency	2014
Dr David Sheridan Dr Simon Bridge Dr Daniel Felmlee Fiona Fenwick Dr R Neely et al.	Omega-3 fatty acids and/or fluvastatin in hepatitis C prior non-responders to combination antiviral therapy - a pilot randomised clinical trial	2014
Dr R Neely	The importance of early diagnosis: How to identify patients with FH for diagnosis and referral	2014
Dr R Neely Richard Bliss Dr Stephen Ball	A 12 cm mass with no symptoms and unremarkable laboratory results	2013
Dr David Sheridan Dr R Neely Professor Margaret Bassendine	Hepatitis C virus and lipids in the era of direct acting antivirals (DAAs)	2013
Professor Margaret Bassendine Dr David Sheridan Dr Simon Bridge Dr Daniel Felmlee Dr R Neely et al.	Lipids and HCV	2013
Dr R Neely	Agarose Electrophoresis Assay for the Quantitative Determination of Lipoprotein-X Using Novel Enzymatic Staining for Total and Free Cholesterol	2012
Dr Ana Jovanovic Dr R Neely	An eggstreme diet; the effect of egg intake on the lipid profile	2012
Dr Jonathan Wallis Dr R Neely	An unusual case of secondary hyperlipidaemia	2012
Dr David Sheridan Dr Simon Bridge Dr Daniel Felmlee Emeritus Professor Geoffrey Toms Dr R Neely et al.	Apolipoprotein-E and hepatitis C lipoviral particles in genotype 1 infection: Evidence for an association with interferon sensitivity	2012
Professor Margaret Bassendine Dr David Sheridan Dr Daniel Felmlee Dr Simon Bridge Emeritus Professor Geoffrey Toms et al.	HCV and the hepatic lipid pathway as a potential treatment target	2011
Dr R Neely Professor Margaret Bassendine	Antisense technology to lower LDL cholesterol	2010
Dr Latika Sibal Dr R Neely Emeritus Professor Philip Home	Friedewald equation underestimates low-density lipoprotein cholesterol at low concentrations in young people with and without Type 1 diabetes	2010
Dr David Sheridan Professor Kim Bartlett Dr Daniel Felmlee Dr Simon Bridge Emeritus Professor Geoffrey Toms et al.	Hypocholesterolaemia in chronic Hepatitis C virus (HCV) infection - Reduced production or increased LDL clearance?	2010
Dr Simon Bridge Dr David Sheridan Dr Daniel Felmlee Dr Soren Nielsen Dr R Neely et al.	Insulin resistance and low-density apolipoprotein B-associated lipoviral particles in hepatitis C virus genotype 1 infection	2010
Dr Simon Bridge Dr David Sheridan Dr Daniel Felmlee Dr Soren Nielsen Dr R Neely et al.	Insulin resistance correlates with low density hepatitis C virus particles in genotype 1 infection	2010
Dr Daniel Felmlee Dr David Sheridan Dr Simon Bridge Dr Soren Nielsen Emeritus Professor Geoffrey Toms et al.	Intravascular Transfer Contributes to Postprandial Increase in Numbers of Very-Low-Density Hepatitis C Virus Particles	2010
Dr Simon Bridge Dr David Sheridan Dr Daniel Felmlee Emeritus Professor Geoffrey Toms Dr R Neely et al.	Low density Hepatitis C virus particles (lipoviral particles) associate with insulin resistance in genotype 1 infection	2010
Dr David Sheridan Dr David Price Dr Matthias Schmid Emeritus Professor Geoffrey Toms Dr Peter Donaldson et al.	Apolipoprotein B-associated cholesterol is a determinant of treatment outcome in patients with chronic hepatitis C virus infection receiving anti-viral agents interferon-alpha and ribavirin	2009
Dr R Neely	Lipid external quality assessment: commutability between external quality assessment and clinical specimens	2008
Dr Harish Datta Dr R Neely	Hepatic surgery-related hypophosphatemia	2007
Dr R Neely	Provision of laboratory services for lipid analysis in the United Kingdom	2007
Dr R Neely Dr Richard Quinton	Complete reversal of adult-onset isolated hypogonadotropic hypogonadism with clomiphene citrate	2006
Dr Stephen Ball Dr Richard Quinton Dr Robert James Professor Simon Pearce Professor Thomas Lennard et al.	Detection of phaeochromocytoma: The emerging role of plasma metanephrines	2006
Dr Richard Quinton Dr R Neely	The investigation and management of critical hyponatraemia	2006
Dr R Neely	Biochemical diagnosis of phaeochromocytoma: The role of plasma metadrenalines	2005
Dr R Neely	Genetic screening protocol for familial hypercholesterolemia which includes splicing defects gives an improved mutation detection rate	2005
Dr Balasubramanian Ravikumar Dr Peter Carey Dr David Cook Dr R Neely Dr Michael Firbank et al.	Real-time assessment of postprandial fat storage in liver and skeletal muscle in health and type 2 diabetes	2005
Dr Chankramath Arun Dr Harish Datta Dr R Neely	Response to atorvastatin in a case of idiopathic hypoalbuminaemia complicated by remnant hyperlipidaemia	2005
Dr R Neely	Is coenzyme Q10 supplementation beneficial in patients with statin associated muscle symptoms and normal creatine kinase levels?	2004
Dr R Neely	Beyond cholesterol - HEART UK survey of analytical services available to UK lipid clinics	2003
Dr Michael Laker Dr R Neely	The investigation and management of dyslipidaemia: An update	2003